This inventor holds 6 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignees: Women's and Children's Hospital, Women's and Children's Hopital. Active years: 2004-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Banksia Park, AU (2004)
- Redwood Park, AU (2008 - 2014)
Company Filing History:
Years Active: 2004-2014
Title: Innovations of Peter John Meikle
Introduction
Peter John Meikle is a notable inventor based in Redwood Park, Australia. He has made significant contributions to the field of medical diagnostics, particularly in the area of lysosomal storage disorders. With a total of 6 patents to his name, Meikle's work has advanced the understanding and testing of these complex diseases.
Latest Patents
One of his latest patents is focused on multiplex screening for lysosomal storage disorders (LSDs). This novel protein profiling method utilizes discovered normalized lysosomal fingerprint patterns to test for Lysosomal Storage Diseases. The fingerprint patterns reveal the health of lysosomal organelles, specific LSDs, and clinical severity. Additionally, he has developed multiplexing bead technology for simultaneous screening of multiple LSDs, normalizing measured enzyme activity or protein levels against other lysosomal proteins, enzymes, or enzyme activities. His work also includes compounds, reagents, and methods for identifying and quantifying multiple target enzymes and proteins.
Career Highlights
Throughout his career, Peter John Meikle has worked with esteemed institutions such as the Women's and Children's Hospital. His innovative approaches have garnered attention and respect in the medical community, contributing to advancements in diagnostic methods.
Collaborations
Meikle has collaborated with notable professionals in his field, including John Joseph Hopwood and Douglas Alexander Brooks. Their combined expertise has furthered research and development in lysosomal storage disorders.
Conclusion
Peter John Meikle's contributions to the field of medical diagnostics through his innovative patents and collaborations have made a significant impact on the understanding and testing of lysosomal storage disorders. His work continues to influence the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile